Startup Spotlight: Carmell Therapeutics Takes Regenerative Medicine to the Next Level with Controlled Degradable Biologic
Orthoworld
, December 11th, 2019
How Can Today’s Founders Navigate A Successful Path From Seed to Exit Answered by Keiretsu Forum Mid-Atlantic Co-Founder
PR Newswire
, October 4th, 2019
Pursuing a Path of Regulatory Rigor: Taking Medtech, Regenerative Medicine to the Next Level
MDDI
, August 13th, 2019
The path to be first — How Carmell Therapeutics could have the 1st BLA-certified regenerative offering for bone healing
Becker's Spine
, June 25th, 2019
Toward A More Robust Regenerative Medicine Regulatory Pathway
Cell & Gene
, April 11th, 2019
Carmell Therapeutics Announces Publication of Results of Pre-Clinical Studies on its Tissue Healing Accelerant for the Treatment of Cutaneous Radiation Injury
Press Release
, March 7th, 2019
Randy Hubbell speaks with Stock News Now at the BIO CEO & Investor Conference 2019 in New York
Press Release
, March 5th, 2019
Carmell Therapeutics to Present at the 21st Annual BIO CEO & Investor Conference in New York
Press Release
, February 4th, 2019
Wendy F. DiCicco joins Carmell Therapeutics’ Board of Directors
Press Release
, January 3rd, 2019
Toward a More Robust Regulatory Pathway — 3 Qs with Carmell Therapeutics’ CEO Randy Hubbell
Press Release
, December 26th, 2018